Cargando…

A SARS-CoV-2 Vaccine Designed for Manufacturability Results in Unexpected Potency and Non-Waning Humoral Response

The rapid development of several highly efficacious SARS-CoV-2 vaccines was an unprecedented scientific achievement that saved millions of lives. However, now that SARS-CoV-2 is transitioning to the endemic stage, there exists an unmet need for new vaccines that provide durable immunity and protecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campbell, Elliot, Dobkin, Julie, Osorio, Louis J., Kolloli, Afsal, Ramasamy, Santhamani, Kumar, Ranjeet, Sant’Angelo, Derek B., Subbian, Selvakumar, Denzin, Lisa K., Anderson, Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145385/ https://www.ncbi.nlm.nih.gov/pubmed/37112744 http://dx.doi.org/10.3390/vaccines11040832

Ejemplares similares

A phosphodiesterase-4 inhibitor reduces lung inflammation and fibrosis in a hamster model of SARS-CoV-2 infection
por: Kolloli, Afsal, et al.
Publicado: (2023)

An intra-cytoplasmic route for SARS-CoV-2 transmission unveiled by Helium-ion microscopy
por: Merolli, Antonio, et al.
Publicado: (2022)

Comprehensive Analysis of Disease Pathology in Immunocompetent and Immunocompromised Hosts following Pulmonary SARS-CoV-2 Infection
por: Ramasamy, Santhamani, et al.
Publicado: (2022)

Inactivation and Elimination of SARS-CoV-2 in Biosamples Using Simple Fixatives and Ultrafiltration
por: Kumar, Ranjeet, et al.
Publicado: (2021)

L-GSH Supplementation in Conjunction With Rifampicin Augments the Treatment Response to Mycobacterium tuberculosis in a Diabetic Mouse Model
por: Beever, Abrianna, et al.
Publicado: (2022)

Host-Directed Therapeutic Strategies for Tuberculosis
por: Kolloli, Afsal, et al.
Publicado: (2017)

Thalidomide and Phosphodiesterase 4 Inhibitors as Host Directed Therapeutics for Tuberculous Meningitis: Insights From the Rabbit Model
por: Kumar, Ranjeet, et al.
Publicado: (2020)

Imaging Architecture of Granulomas Induced by Mycobacterium tuberculosis Infections with Single-Molecule FISH
por: Kumar, Ranjeet, et al.
Publicado: (2023)

Immunometabolism of Phagocytes During Mycobacterium tuberculosis Infection
por: Kumar, Ranjeet, et al.
Publicado: (2019)

Aggregation state of Mycobacterium tuberculosis impacts host immunity and augments pulmonary disease pathology
por: Kolloli, Afsal, et al.
Publicado: (2021)

Effect of Iron Supplementation on the Outcome of Non-Progressive Pulmonary Mycobacterium tuberculosis Infection
por: Kolloli, Afsal, et al.
Publicado: (2019)

Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis
por: Ramasamy, Santhamani, et al.
Publicado: (2021)

Dynamics of temporal immune responses in nonhuman primates and humans immunized with COVID-19 vaccines
por: Ravindran, Resmi, et al.
Publicado: (2023)

Effects of Glutathione Diminishment on the Immune Responses against Mycobacterium tuberculosis Infection
por: Cao, Ruoqiong, et al.
Publicado: (2021)

Everolimus-induced effector mechanism in macrophages and survivability of Erdman, CDC1551 and HN878 strains of Mycobacterium tuberculosis infection
por: Cao, Ruoqiong, et al.
Publicado: (2021)

YY1(lo) NKT cells are dedicated IL-10 producers
por: Darcy, Patrick W., et al.
Publicado: (2020)

Zbtb16 (PLZF) is stably suppressed and not inducible in non-innate T cells via T cell receptor-mediated signaling
por: Zhang, Sai, et al.
Publicado: (2015)

Liposomal Glutathione Helps to Mitigate Mycobacterium tuberculosis Infection in the Lungs
por: Kachour, Nala, et al.
Publicado: (2022)

Accelerated waning of the humoral response to COVID-19 vaccines in obesity
por: van der Klaauw, Agatha A., et al.
Publicado: (2023)

Waning and boosting of functional humoral immunity to SARS-CoV-2
por: Tong, X., et al.
Publicado: (2022)

1979. Waning of humoral immunity depending on the types of COVID-19 vaccine
por: Lim, So Yun, et al.
Publicado: (2022)

Reinfection with SARS-CoV-2 and Waning Humoral Immunity: A Case Report
por: Goldman, Jason D., et al.
Publicado: (2022)

Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry
por: Xu, Chuan, et al.
Publicado: (2021)

The Waning of the Plague
Publicado: (1897)

Recollections of Charlie: Dr. Charles Alderson Janeway, Jr. (1943-2003)
por: Sant'Angelo, Derek B.
Publicado: (2003)

The waning war on cancer.
Publicado: (1995)

A Waning Superstition
Publicado: (1902)

Mental Disease on the Wane
por: Banschikov, Vasili, et al.
Publicado: (1965)

Boosting of Waned Humoral and Cellular Responses to SARS-CoV-2 Variants of Concern Among Patients with Cancer
por: McKenzie, Duncan R., et al.
Publicado: (2022)

Occurrence of COVID-19 Symptoms During SARS-CoV-2 Infection Defines Waning of Humoral Immunity
por: Wu, Jun, et al.
Publicado: (2021)

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
por: Levin, Einav G., et al.
Publicado: (2021)

Waning humoral immune responses to inactivated SARS-CoV-2 vaccines in patients with severe liver disease
por: Chen, Zhiwei, et al.
Publicado: (2022)

The Waxing, Waning, and Predictors of Humoral Responses to Vector-Based SARS-CoV-2 Vaccine in Hemodialysis Patients
por: Fu, Chung-Ming, et al.
Publicado: (2022)

Is the Bacteriological Theory of Disease Waning?
Publicado: (1896)

Is the Influence of the Medical Profession on the Wane?
Publicado: (1890)

The Paf oncogene is essential for hematopoietic stem cell function and development
por: Amrani, Yacine M., et al.
Publicado: (2011)

Editorial: Innate immune evasion strategies during microbial infection
por: Subbian, Selvakumar
Publicado: (2023)

Neuroinflammation in Alzheimer's disease wanes with age
por: Hoozemans, Jeroen JM, et al.
Publicado: (2011)

Waning and boosting: on the dynamics of immune status
por: Diekmann, O., et al.
Publicado: (2018)

Infections in the tropics- is the bane of yesteryears waning?
por: Prakash, Anupam
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qbo72535b0scc0le3impj1nq7n